Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Infrared Light Treatment Tested in People With Hard-to-Treat Epilepsy

Tests infrared light treatment in adults with drug-resistant epilepsy.

Plain-language title generated from the registry record
Registry title: Infrared Photobiomodulation in Humans With Epilepsy

Key facts

Where
Boston, United StatesSee the site

Where in United States

  • BIDMCBoston, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Beth Israel Deaconess Medical Center
Trial code
NCT07145489
Record updated
4 February 2026
Original description
Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment has shown promise as a possible way to reduce seizures, but it has not been tested in humans for this. The investigators are interested to know if it can reduce seizures, and how comfortable it is to be treated with this therapy.Read full original descriptionShow less

An Open Label Pilot Study of Infrared Photobiomodulation in Humans With Epilepsy

Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment has shown promise as a possible way to reduce seizures, but it has not been tested in humans for this. The investigators are interested to know if it can reduce seizures, and how comfortable it is to be treated with this therapy.

Inclusion: Drug resistant epilepsy; Age 18 or older; Average seizure rate of at least 2 seizures per month; Accurate seizure diary with at least 3 months recorded.

Exclusion: Taking any medication that can cause photosensitivity; Cancer on scalp; Implanted intracranial neurostimulation device (DBS or RNS); Intracranial shunt; Skin photosensitivity.

ClinicalTrials.gov NCT07145489